Abstract
Due to the implementation of the national program “Fight against Oncological Diseases”, a number of anticancer drugs, mainly for targeted therapy and immunotherapy, are annually registered in Russia and included in the list of vital and essential medicines [1]. Purpose: to study the structure of adverse reactions (ADR) when using anticancer drugs based on the analysis of spontaneous reports in the Chuvash Republic for the period 01.09.2008 to 31.12.2021.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
